Health and Fitness Health and Fitness

Thu, April 19, 2012

[ Thu, Apr 19th 2012 ] - Market Wire

Gilead anuncia ndices provisionales de respuesta .. 977 ms ribavirina en pacientes con hepatitis C de

[ Thu, Apr 19th 2012 ] - Market Wire

Watson Confirms Glumetza Patent Challenge

[ Thu, Apr 19th 2012 ] - Market Wire

CareFusion and Cerner Integrate Smart Pump Techno .. to Help Improve Medication Safety and Efficiency

[ Thu, Apr 19th 2012 ] - Market Wire

Synta to Host First-Quarter 2012 Conference Call on May 3, 2012

[ Thu, Apr 19th 2012 ] - Market Wire

CytoSorbents Receives European Trademark for CytoSorb(R)

[ Thu, Apr 19th 2012 ] - Market Wire

Cytokinetics Announces CK-2017357 Receives Fast T .. for the Potential Treatment of Amyotrophic Later

[ Thu, Apr 19th 2012 ] - Market Wire

EnteroMedics to Host First Quarter 2012 Financial .. sults Conference Call and Provide Business Update

[ Thu, Apr 19th 2012 ] - Market Wire

Given Imaging to Host First Quarter 2012 Financial Results Conference Call on May 9, 2012

[ Thu, Apr 19th 2012 ] - Market Wire

MSD Reports Phase III Study Results Evaluating An .. sed With VICTRELIS (boceprevir) Combination Thera

[ Thu, Apr 19th 2012 ] - Market Wire

Merck Reports Phase III Study Results Evaluating .. Used With VICTRELIS (boceprevir) Combination Ther

[ Thu, Apr 19th 2012 ] - Market Wire

ZELTIQ Announces Criminal Judgments in Its Favor Ordered by Court in South Korea

[ Thu, Apr 19th 2012 ] - Market Wire

State of Ohio Selects Healthways to Provide Comprehensive Population Health Management Program

[ Thu, Apr 19th 2012 ] - Market Wire

Marina Biotech Regains Intellectual Property Righ .. M) Technology for Agriculture and Veterinary Uses

[ Thu, Apr 19th 2012 ] - Market Wire

Human Genome Sciences Announces Unsolicited Offer .. ; HGS Board of Directors Authorizes Exploration o

[ Thu, Apr 19th 2012 ] - Market Wire

Gilead Announces Early Sustained Virologic Respon .. avirin in Genotype 1 Treatment-Nave Hepatitis C P

[ Thu, Apr 19th 2012 ] - Market Wire

Gilead Announces Sustained Virologic Response Dat .. 977 Plus Pegylated Interferon and Ribavirin in Ge

[ Thu, Apr 19th 2012 ] - Market Wire

Abbott Presents Positive Results from Interferon- .. Pilotquot;; Study for the Treatment of Hep

Wed, April 18, 2012

[ Wed, Apr 18th 2012 ] - Market Wire

Vertex fait progresser INCIVEKa" (tlaprvir) ainsi .. mdicaments au stade du dveloppement avec comme ob

[ Wed, Apr 18th 2012 ] - Market Wire

Cannabis Science in Final Negotiations to Purchas .. 00 Square Foot Cancer Centre in Arizona With Over

[ Wed, Apr 18th 2012 ] - Market Wire

Gilead Sciences presenta nuevos datos sobre la he .. o europeo sobre enfermedades hepticas esta semana

[ Wed, Apr 18th 2012 ] - Market Wire

Research Alert -- Empire Asset Management Co. Ini .. age on Pacira Pharmaceuticals Inc. (NASDAQ: PCRX)

[ Wed, Apr 18th 2012 ] - Market Wire

Sirona to Report Second Quarter Fiscal 2012 Results on May 4th

[ Wed, Apr 18th 2012 ] - Market Wire

Roche decides not to extend its tender offer for Illumina, Inc.

[ Wed, Apr 18th 2012 ] - Market Wire

Sunrise Senior Living Launches Senior Eatsa" Food Blog

[ Wed, Apr 18th 2012 ] - Market Wire

Data from ASCEND-PD Phase III Study of IPX066 to .. d at the American Academy of Neurology Conference

[ Wed, Apr 18th 2012 ] - Market Wire

Cytomedix Announces Multiple Poster Presentations .. the Symposium on Advanced Wound Care Spring 2012

[ Wed, Apr 18th 2012 ] - Market Wire

Guided Therapeuticsa LuViva Advanced Cervical Sca .. nveiled at Prestigious British Medical Conference

[ Wed, Apr 18th 2012 ] - Market Wire

Black Smoker Acquires B.C. Graphite Project;; Contiguous to Eagle Graphite Corp.

[ Wed, Apr 18th 2012 ] - Market Wire

Mylan Announces Expansion in Ireland

[ Wed, Apr 18th 2012 ] - Market Wire

Vanda Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 8, 2012

[ Wed, Apr 18th 2012 ] - Market Wire

Boston Therapeutics Receives First Purchase Order From Advance Pharmaceutical

[ Wed, Apr 18th 2012 ] - Market Wire

NeuroMetrix Files 510(k) for SENSUSa" Pain Therapy Device

[ Wed, Apr 18th 2012 ] - Market Wire

Synthetic Biologics Appoints Michael Kaleko, M.D., Ph.D., as Scientific Director

[ Wed, Apr 18th 2012 ] - Market Wire

Crown Dynamics Receives Initial Purchase Order From Quest Products, Inc.

Tue, April 17, 2012

[ Tue, Apr 17th 2012 ] - Market Wire

Chairman &;; CEO of TapImmune Says Lice .. sed HER2/neu Antigen Technology Is a Game Changer

[ Tue, Apr 17th 2012 ] - Market Wire

WuXi PharmaTech Schedules First-Quarter 2012 Earnings Release

[ Tue, Apr 17th 2012 ] - Market Wire

Select Medical Holdings Corporation to Announce First Quarter 2012 Results on Thursday, May 3

[ Tue, Apr 17th 2012 ] - Market Wire

Thoratec Surpasses 10,000 HeartMate II Implants Worldwide

[ Tue, Apr 17th 2012 ] - Market Wire

Sequenom Announces Amendment to Multi-Year Supply Agreement with Illumina

[ Tue, Apr 17th 2012 ] - Market Wire

Dyax and Eclipse Therapeutics Announce Oncology Antibody License Agreement

[ Tue, Apr 17th 2012 ] - Market Wire

DaVita Named to WorldBlu List of Most Democratic Workplaces

[ Tue, Apr 17th 2012 ] - Market Wire

Derma Sciences Completes MedEfficiency Acquisition

[ Tue, Apr 17th 2012 ] - Market Wire

Implant Sciences Adds Printing Capability to QS-H150 Explosives Trace Detector

[ Tue, Apr 17th 2012 ] - Market Wire

BioDelivery Sciences Awarded Patent Resulting in $15 Million Milestone Payment

[ Tue, Apr 17th 2012 ] - Market Wire

Jennerex Elects Dr. Mitchell H. Gold to Board of Directors

[ Tue, Apr 17th 2012 ] - Market Wire

Texas Health Resources and Healthways Announce Te .. Well-Being and Reduce Health-Related Costs in Nor

[ Tue, Apr 17th 2012 ] - Market Wire

ImmunoGen, Inc. Announces the IND Is Now Active f .. e-Receptor Targeting Anticancer Compound, IMGN853

[ Tue, Apr 17th 2012 ] - Market Wire

ImmunoGen, Inc. Initiates Phase I Trial in Non-Ho .. mphoma with Its Novel IMGN529 Anticancer Compound

[ Tue, Apr 17th 2012 ] - Market Wire

Shengtai Pharmaceutical, Inc. Announces Receipt of Non Binding Going Private Proposal

[ Tue, Apr 17th 2012 ] - Market Wire

Given Imaging Designates Policlinico A. Gemelli, .. as First Colon Capsule Endoscopy Center of Excell

[ Tue, Apr 17th 2012 ] - Market Wire

Waters Brings Awarding-Winning UltraPerformance Convergence Chromatography to Analytica 2012

Mon, April 16, 2012

[ Mon, Apr 16th 2012 ] - Market Wire

MELA Sciences to Release First Quarter Financial .. and Host Conference Call on Thursday, May 3, 2012

[ Mon, Apr 16th 2012 ] - Market Wire

Merck en Endocyte sluiten een exclusieve, wereldw .. wikkeling en het in de handel brengen van vintafo

[ Mon, Apr 16th 2012 ] - Market Wire

Reliv Introduces Breakthrough Approach to Optimal Kids' Nutrition

[ Mon, Apr 16th 2012 ] - Market Wire

Lilly Diabetes and Walgreens Launch Diabetes Hypoglycemia Awareness Campaign

[ Mon, Apr 16th 2012 ] - Market Wire

VistaGen Licenses Breakthrough Stem Cell Culture .. ent of Drug Screening and Cell Therapy for Immune

[ Mon, Apr 16th 2012 ] - Market Wire

InspireMD Announces Continued Progress in MASTER Trial

[ Mon, Apr 16th 2012 ] - Market Wire

Ruling in Texas Could Provide New Opportunities for Stem Cell Companies

[ Mon, Apr 16th 2012 ] - Market Wire

Equity Research on Endo Pharmaceuticals Holdings .. Inc. - Drug Manufacturers Acquiring and Expanding

[ Mon, Apr 16th 2012 ] - Market Wire

Cynapsus Provides Update and 2012 Outlook

[ Mon, Apr 16th 2012 ] - Market Wire

Trimel Pharmaceuticals Corporation Provides CompleoTRT(TM) Phase III Recruitment Update

[ Mon, Apr 16th 2012 ] - Market Wire

Merck and Endocyte Enter Exclusive Worldwide Agre .. alize Phase III Cancer Candidate Vintafolide (EC1

[ Mon, Apr 16th 2012 ] - Market Wire

Reintegration Awards Recognize Service to People With Mental Illness

[ Mon, Apr 16th 2012 ] - Market Wire

Vanda Pharmaceuticals Acquires Rights to NK-1 Receptor Antagonist from Eli Lilly and Company

[ Mon, Apr 16th 2012 ] - Market Wire

Percutaneous Tibial Nerve Stimulation (PTNS) for .. ffirmation of Efficacy and Safety in Agency for H

[ Mon, Apr 16th 2012 ] - Market Wire

Medtronic Endurant AAA Stent Graft Shows Durable Performance at Two Years in U.S. Study

[ Mon, Apr 16th 2012 ] - Market Wire

Express Scripts Launches ScreenRx(SM), Industry's .. ly Detection and Tailored Interventions to Addres

[ Mon, Apr 16th 2012 ] - Market Wire

Illumina to Announce First Quarter 2012 Results on Monday, April 23, 2012

Sun, April 15, 2012

[ Sun, Apr 15th 2012 ] - Market Wire

DaVita Announces CFO Transition

[ Sun, Apr 15th 2012 ] - Market Wire

Biodel Reports Positive Top-Line Results from Stu .. erimental Ultra-Rapid-Acting Insulin Formulations

Sat, April 14, 2012

[ Sat, Apr 14th 2012 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Investigation of eResearchTechnology, Inc.

Fri, April 13, 2012

[ Fri, Apr 13th 2012 ] - Market Wire

Five Star Quality Care, Inc. Enters New $150 Million Credit Facility

[ Fri, Apr 13th 2012 ] - Market Wire

Alnylam to Webcast Presentation at Future Leaders in the Biotech Industry Conference

[ Fri, Apr 13th 2012 ] - Market Wire

Quidel to Hold First Quarter 2012 Financial Results Conference Call on April 25, 2012

[ Fri, Apr 13th 2012 ] - Market Wire

Lakeland Industries to Report Fiscal Fourth Quart .. ults and Conduct Conference Call on Wednesday, Ap

[ Fri, Apr 13th 2012 ] - Market Wire

Immunovaccine Inc. Named "Best Early-Stage Vaccin .. the 5th Vaccine Industry Excellence (ViE) Awards

[ Fri, Apr 13th 2012 ] - Market Wire

Lakeland Industries Announces Significant Developments in Its Global Transformation

[ Fri, Apr 13th 2012 ] - Market Wire

BOTOX Cosmetic (onabotulinumtoxinA) Celebrates 10 .. ary of U.S. Food and Drug Administration Approval

[ Fri, Apr 13th 2012 ] - Market Wire

NxStage to Report First Quarter Fiscal 2012 Financial Results

[ Fri, Apr 13th 2012 ] - Market Wire

Unilife Corporation to Announce Financial Results .. al 2012 Third Quarter on Thursday, April 26, 2012

[ Fri, Apr 13th 2012 ] - Market Wire

Infinity Pharmaceuticals to Present at Two Upcoming Conferences

[ Fri, Apr 13th 2012 ] - Market Wire

Affymax and Takeda Announce Centers for Medicare .. igned a Q-Code for OMONTYS (Peginesatide) Injecti

[ Fri, Apr 13th 2012 ] - Market Wire

Tornier Announces 2012 Facility Consolidations

[ Fri, Apr 13th 2012 ] - Market Wire

Oncothyreon to Present at Future Leaders in the Biotech Industry Conference

[ Fri, Apr 13th 2012 ] - Market Wire

Threshold Pharmaceuticals Announces Presentation .. d Webcast at BioCentury Future Leaders Conference

[ Fri, Apr 13th 2012 ] - Market Wire

Mylan Launches First Generic Version of Lescol Capsules

[ Fri, Apr 13th 2012 ] - Market Wire

Theratechnologies Announces Financial Results for First Quarter of 2012

[ Fri, Apr 13th 2012 ] - Market Wire

Delcath Announces First Patient Treatment Using Second Generation Hemofiltration Cartridge

Thu, April 12, 2012

[ Thu, Apr 12th 2012 ] - Market Wire

Sangamo BioSciences Announces Presentation at the .. Future Leaders in the Biotech Industry Conference

[ Thu, Apr 12th 2012 ] - Market Wire

MSA Schedules First Quarter Earnings Webcast

[ Thu, Apr 12th 2012 ] - Market Wire

The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Direct

[ Thu, Apr 12th 2012 ] - Market Wire

Killing Cancer Premiered on April 5;; Cann .. t Melamede and Filmmaker Henry Miller Weigh in on

[ Thu, Apr 12th 2012 ] - Market Wire

Healthnostics Stockholders to Receive Multiple Stock Issuances

[ Thu, Apr 12th 2012 ] - Market Wire

Masimo Pronto-7a" Receives China and South Korea Regulatory Clearances

[ Thu, Apr 12th 2012 ] - Market Wire

Advances in Stereotactic Radiosurgery are Enablin .. fective, Non-Invasive Treatment for Spinal Tumors

[ Thu, Apr 12th 2012 ] - Market Wire

Rosetta Genomics to Raise $1.38 Million in Registered Direct Offering

[ Thu, Apr 12th 2012 ] - Market Wire

CryoLife Announces Release Date and Teleconferenc .. Details for 2012 First Quarter Financial Results

[ Thu, Apr 12th 2012 ] - Market Wire

CytRx Announces Issuance of Key U.S. Patent Covering INNO-206 Linker Technology

[ Thu, Apr 12th 2012 ] - Market Wire

Research on Mylan Inc. and Watson Pharmaceuticals Inc. - Generic Drug Makers Take to the Courts

[ Thu, Apr 12th 2012 ] - Market Wire

Valeant Pharmaceuticals to Acquire Pedinol

[ Thu, Apr 12th 2012 ] - Market Wire

Varian Medical Systems Holds Workshop in Advanced Radiotherapy Techniques for African Clinicians

[ Thu, Apr 12th 2012 ] - Market Wire

AcelRx Announces Initiation of Second Phase 3 Cli .. ufentanil NanoTab PCA System, for the Treatment o

[ Thu, Apr 12th 2012 ] - Market Wire

Nuvo Research Provides Pennsaid Update

[ Thu, Apr 12th 2012 ] - Market Wire

PDL BioPharma to Hold Annual Meeting of Stockholders on June 5, 2012

[ Thu, Apr 12th 2012 ] - Market Wire

Perceptive Informatics Enables Greater Trial Supp .. iciency With New Site Inventory Management Module

Wed, April 11, 2012

[ Wed, Apr 11th 2012 ] - Market Wire

Lilly Confirms Date and Conference Call for First-Quarter 2012 Financial Results Announcement

[ Wed, Apr 11th 2012 ] - Market Wire

Harwood Feffer LLP Announces Investigation of Optimer Pharmaceuticals, Inc.

[ Wed, Apr 11th 2012 ] - Market Wire

Boston Scientific annonce le lancement en europe de la gamme de stimulateurs cardiaques INGENIOa"

[ Wed, Apr 11th 2012 ] - Market Wire

Prasco Expands Authorized Generic Product Line with Vancocin HCl Capsules

[ Wed, Apr 11th 2012 ] - Market Wire

Sarah Ashby Joins Psychemedics Corporation As Associate General Counsel

[ Wed, Apr 11th 2012 ] - Market Wire

The Briscoe Law Firm and Powers Taylor, LLP Inves .. iduciary Duty by the Officers and Directors of Ch

[ Wed, Apr 11th 2012 ] - Market Wire

The Law Firm of Levi & Korsinsky, LLP Announces I .. eaches of Fiduciary Duty by the Board of eResearc

[ Wed, Apr 11th 2012 ] - Market Wire

Merit Medical Systems to Announce First Quarter 2012 Results on April 24, 2012

[ Wed, Apr 11th 2012 ] - Market Wire

The Briscoe Law Firm and Powers Taylor, LLP Inves .. Research Technology, Inc. by Genstar Capital, LLC

[ Wed, Apr 11th 2012 ] - Market Wire

Cytomedix Reports Publication of Positive AutoloGel Wound Healing Data in Ostomy Wound Management

[ Wed, Apr 11th 2012 ] - Market Wire

Analytical Reports on Hospira Inc. and Valeant Ph .. Drug Delivery Companies Expanding Reach and Offe

[ Wed, Apr 11th 2012 ] - Market Wire

Lorus Therapeutics Announces Allowance of United States Patent for Anticancer Drug LOR-253

[ Wed, Apr 11th 2012 ] - Market Wire

AcelRx Pharmaceuticals Receives Two Notices of Al .. e for Small-Volume Oral Transmucosal Dosage Forms

[ Wed, Apr 11th 2012 ] - Market Wire

Threshold Pharmaceuticals Earns $20 Million Miles .. for Positive Results From Phase 2 Trial of TH-302

[ Wed, Apr 11th 2012 ] - Market Wire

Dyax Launches Hereditary Angioedema Genetic Couns .. ents and Family Members about Disease and Inherit

[ Wed, Apr 11th 2012 ] - Market Wire

InVivo Therapeuticsa CEO Frank Reynolds Scheduled .. iliates in Charlotte, Indianapolis and Greensboro

[ Wed, Apr 11th 2012 ] - Market Wire

Mymetics Appoints Grant Pickering CEO and Christopher Henney Chairman

Tue, April 10, 2012

[ Tue, Apr 10th 2012 ] - Market Wire

eResearchTechnology, Inc. (ERT) Shareholder Alert .. ounces Investigation of Acquisition by Affiliates

[ Tue, Apr 10th 2012 ] - Market Wire

Amgen to Acquire Privately Held KAI Pharmaceuticals

[ Tue, Apr 10th 2012 ] - Market Wire

Hamilton Thorne Receives Patent Approval on Innov .. i(R) Target Locator for Its Line of Laser Systems

[ Tue, Apr 10th 2012 ] - Market Wire

Medtronic Receives FDA Approval to Treat Mildly S .. re Patients Through Expanded Indication for CRT-D

[ Tue, Apr 10th 2012 ] - Market Wire

Biotech Stocks Look to Benefit From JOBS Act

[ Tue, Apr 10th 2012 ] - Market Wire

iBio Announces Production of Biosimilar Palivizumab with its iBioLauncha" Technology

[ Tue, Apr 10th 2012 ] - Market Wire

Boston Therapeutics PAZ320 Interim Clinical Trial Safety Results

[ Tue, Apr 10th 2012 ] - Market Wire

Implant Sciences Explosives Trace Detection Equipment to Be Deployed at the Summit of the Americas

[ Tue, Apr 10th 2012 ] - Market Wire

NeuroMetrix to Exhibit at the Midwest Podiatry Conference

[ Tue, Apr 10th 2012 ] - Market Wire

Acorda Therapeutics to Provide Pipeline Update at Upcoming R&D Day

[ Tue, Apr 10th 2012 ] - Market Wire

ERT Announces Acquisition by Genstar Capital

[ Tue, Apr 10th 2012 ] - Market Wire

Delcath Announces Agreement With Netherlands Canc .. enhoek Hospital for Training and Launch of Hepati

[ Tue, Apr 10th 2012 ] - Market Wire

OncoSec Executive Team Contributes to Manufacturi .. ny Profile Featured in San Diego Business Journal

[ Tue, Apr 10th 2012 ] - Market Wire

Akorn Announces the Approval and Launch of Generic Vancocin

[ Tue, Apr 10th 2012 ] - Market Wire

Crown Dynamics AIR(R) by Airware to Be Distributed by Quest Products, Inc.

[ Tue, Apr 10th 2012 ] - Market Wire

NTRR to Begin Clinical Trials of Improved Weight Loss Formula

[ Tue, Apr 10th 2012 ] - Market Wire

Santarus Appoints Alessandro E. Della Ch and Matthew W. Strobeck to Board of Directors

Mon, April 9, 2012

[ Mon, Apr 09th 2012 ] - Market Wire

HealthSouth to Hold Annual Stockholder Meeting

[ Mon, Apr 09th 2012 ] - Market Wire

Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology

[ Mon, Apr 09th 2012 ] - Market Wire

Data Published in Premier Endocrinology Journal S .. ificant Clinical Improvement in Patients With End

[ Mon, Apr 09th 2012 ] - Market Wire

Exclusive Video Q&;;A With Timothy M. Mayleben, CEO of Aastrom Biosciences

[ Mon, Apr 09th 2012 ] - Market Wire

Novadaq Announces Closing of Underwritten Offerin .. Including Full Exercise of Over-Allotment Option

[ Mon, Apr 09th 2012 ] - Market Wire

Abbott Receives Approval for Next-Generation XIENCE PRIMEa" Drug Eluting Stent in Japan

[ Mon, Apr 09th 2012 ] - Market Wire

FDA Panel Scheduled to Review Edwards Sapien Valve for High-Risk Patients on June 13

[ Mon, Apr 09th 2012 ] - Market Wire

Accuray Incorporated to Report Financial Results for Third Quarter of Fiscal 2012

[ Mon, Apr 09th 2012 ] - Market Wire

Agadia Systems Inc. and Comprehensive Care Corpor .. rovide Services to CompCare's Major Health Networ

[ Mon, Apr 09th 2012 ] - Market Wire

CytoSorbents Corporation Establishes European Subsidiary

[ Mon, Apr 09th 2012 ] - Market Wire

ADVENTRX Announces Establishment of Regulatory Advisory Board

[ Mon, Apr 09th 2012 ] - Market Wire

InspireMD Appoints Robert Ratini as Vice President of Sales and Marketing

[ Mon, Apr 09th 2012 ] - Market Wire

Johnson amp;; Johnson Announces Resignation of Sheri S. McCoy

[ Mon, Apr 09th 2012 ] - Market Wire

Optimer Pharmaceuticals Announces Personnel Changes

[ Mon, Apr 09th 2012 ] - Market Wire

Centene Corporation Notified of Decision for Ohio Medicaid Contract

[ Mon, Apr 09th 2012 ] - Market Wire

Concord Medical Announces Participation in Upcoming Investor Events

[ Mon, Apr 09th 2012 ] - Market Wire

BARDA Delivers Notice of Intent to Exercise Addit .. l Contract Options With Aeolus Worth $9.1 Million

Fri, April 6, 2012

[ Fri, Apr 06th 2012 ] - Market Wire

FDA Approves Amyvida" (Florbetapir F 18 Injection .. valuated for Alzheimer's Disease and Other Causes

[ Fri, Apr 06th 2012 ] - Market Wire

Skilled Healthcare to Release First Quarter 2012 Results on May 2, 2012

[ Fri, Apr 06th 2012 ] - Market Wire

Notice of Redemption and Withdrawal of Class of Securities from Listing on the NYSE

[ Fri, Apr 06th 2012 ] - Market Wire

SciClone Announces Board of Directors and Officer Changes

[ Fri, Apr 06th 2012 ] - Market Wire

Federman &;; Sherwood Announces That a .. it Has Been Filed Against Chelsea Therapeutics In

[ Fri, Apr 06th 2012 ] - Market Wire

Molina Healthcare of California Selected to Participate in Dual Eligible Demonstration Project

[ Fri, Apr 06th 2012 ] - Market Wire

A Covidien Anuncia Acordo Definitivo para Adquirir Oridion Systems Ltd.

[ Fri, Apr 06th 2012 ] - Market Wire

Boston Therapeutics Launches SUGARDOWN(R) Publicity Campaign

[ Fri, Apr 06th 2012 ] - Market Wire

American Oriental Bioengineering Inc. Receives NY .. lure to Satisfy a Continued Listing Rule or Stand

[ Fri, Apr 06th 2012 ] - Market Wire

Par Pharmaceutical Begins Shipment of Generic Provigil

Thu, April 5, 2012

[ Thu, Apr 05th 2012 ] - Market Wire

The Law Firm of Levi & Korsinsky LLP Launches an .. reaches of Fiduciary Duty by the Board of Directo

[ Thu, Apr 05th 2012 ] - Market Wire

Faruqi amp;; Faruqi, LLP Announces Investi .. ation of Chelsea Therapeutics International, Ltd.

[ Thu, Apr 05th 2012 ] - Market Wire

Helix BioPharma Corp. Reconstituted Board of Directors Provides Update to Shareholders

[ Thu, Apr 05th 2012 ] - Market Wire

Life Technologies Sets 1st Quarter 2012 Earnings Release Date for Tuesday, April 24, 2012

[ Thu, Apr 05th 2012 ] - Market Wire

[ Thu, Apr 05th 2012 ] - Market Wire

Aeolus Pharmaceuticals Announces Date and Time fo .. rda Contract and Corporate Update Conference Call

[ Thu, Apr 05th 2012 ] - Market Wire

Covance Inc. Invites You to Join the Webcast of I .. st Quarter 2012 Financial Results Conference Call

[ Thu, Apr 05th 2012 ] - Market Wire

InspireMD Announces Closing of Private Placement Financing

[ Thu, Apr 05th 2012 ] - Market Wire

France's Transparency Commission (CT) Issues Favo .. pinion for Reimbursement of Esbriet (pirfenidone)

[ Thu, Apr 05th 2012 ] - Market Wire

Mylan Sues FDA Seeking Ruling That Teva Holds No Exclusivity for Its Generic Version of Provigil

[ Thu, Apr 05th 2012 ] - Market Wire

Verisante Chosen as "Pick of the Street" in the Technology and Life Sciences Sector

[ Thu, Apr 05th 2012 ] - Market Wire

Analytical Reports on DaVita Inc. and HEALTHSOUTH .. th Services Looking to Expansion to Escape Reform

[ Thu, Apr 05th 2012 ] - Market Wire

Life Technologies Receives the First and Only PCR .. for Salmonella Enteritidis in Poultry Eggs and E

[ Thu, Apr 05th 2012 ] - Market Wire

Implant Sciences Hires Quality Manager to Prepare Company for Increased Production

[ Thu, Apr 05th 2012 ] - Market Wire

STAAR Surgical Appoints Samuel Gesten General Counsel and Secretary

[ Thu, Apr 05th 2012 ] - Market Wire

Delcath Receives European Regulatory Approval for Second Generation Hemofiltration Cartridge

[ Thu, Apr 05th 2012 ] - Market Wire

Transcept Pharmaceuticals Announces National Product Launch of Intermezzo by Purdue Pharma L.P.

Wed, April 4, 2012

[ Wed, Apr 04th 2012 ] - Market Wire

Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP (aflibercept)

[ Wed, Apr 04th 2012 ] - Market Wire

Solta Medical presente Liposonix lors de l'AMWC d .. eux millions de traitements esthetiques effectues

[ Wed, Apr 04th 2012 ] - Market Wire

The Rosen Law Firm Announces Investigation Against Tibet Pharmaceuticals Inc.

[ Wed, Apr 04th 2012 ] - Market Wire

Cascade Technologies Corporation Signs Definitive .. Financing to Support Its Lead Product Candidates

[ Wed, Apr 04th 2012 ] - Market Wire

Warnex Provides an Update on its Operations

[ Wed, Apr 04th 2012 ] - Market Wire

MiMedx Exceeds Revenue Goal for First Quarter of 2012

[ Wed, Apr 04th 2012 ] - Market Wire

The Law Firm of Levi amp;; Korsinsky Notif .. Their Investment in BioSante Pharmaceuticals, Inc

[ Wed, Apr 04th 2012 ] - Market Wire

Life Technologies to Accelerate Adoption of Next- .. ration Sequencing in HLA Through Key Partnerships

[ Wed, Apr 04th 2012 ] - Market Wire

Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2012 Results

[ Wed, Apr 04th 2012 ] - Market Wire

Approximately 48 Hours Remain;; Former Lou .. ahn Swick &;; Foti, LLC Remind Investor

[ Wed, Apr 04th 2012 ] - Market Wire

Abbott to Present Positive Phase 2 Results from M .. es of Combination Regimens for the Treatment of H

[ Wed, Apr 04th 2012 ] - Market Wire

Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012

[ Wed, Apr 04th 2012 ] - Market Wire

Healthnostics Announces Special Distribution

[ Wed, Apr 04th 2012 ] - Market Wire

Investigator-Sponsored Study of PLC's RenalGuard( .. tality and Fewer Adverse Events Than Alternatives

[ Wed, Apr 04th 2012 ] - Market Wire

AdCare Health Systems to Present at Imperial Capital Healthcare Investor Forum on April 17, 2012

[ Wed, Apr 04th 2012 ] - Market Wire

Promising Clinical Data in Breast and Liver Cance .. Therapeutic Potential of Peregrine's Bavituximab

[ Wed, Apr 04th 2012 ] - Market Wire

Access Pharmaceuticals MuGard on Formulary at Memorial Sloan-Kettering Cancer Center

Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry Conference

_{//health-fitness.news-articles.net/content/2012/ .. -leaders-in-the-biotech-industry-conference.html}
^{Published in Health and Fitness on Thursday, April 12th 2012 at 14:36 GMT by Market Wire}

Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry... -- RICHMOND, Calif., April 12, 2012 /PRNewswire/ --

Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry Conference

[ ]

RICHMOND, Calif., April 12, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: [ SGMO ]) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an overview of the company's business strategy at 1:30 pm ET on Friday, April 20, 2012, at the Future Leaders in the Biotech Industry Conference which will be held in New York City.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section [ http://investor.sangamo.com/index.cfm ] under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS. Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia and hemoglobinopathies such as sickle cell anemia and beta-thalassemia, and a program in Parkinson's disease. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). Engineering of ZFPs that recognize a specific DNA sequence enables the creation of sequence-specific ZFP Nucleases (ZFNs) for gene modification and ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function. Sangamo has entered into a strategic collaboration with Shire to develop therapeutics for hemophilia and other monogenic diseases and has established strategic partnerships with companies in non-therapeutic applications of its technology including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the company's website at [ www.sangamo.com ]

ZFP Therapeutic® is a registered trademark of Sangamo BioSciences, Inc.

SOURCE Sangamo BioSciences, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.sangamo.com ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire